Form 4: Elevance Health CAO & Controller Ronald Penczek Reports Stock Transactions
SEC Form 4 Filing
Ronald Penczek, CAO & Controller of Elevance Health, reports acquisition and disposal of common stock and derivative securities, including stock options and restricted share units, in a recent SEC Form 4 filing.
Summary
- Ronald Penczek, CAO & Controller of Elevance Health, filed a Form 4 with the SEC.
- The filing details transactions involving Elevance Health's common stock and derivative securities.
- On March 1, 2024, Penczek disposed of 383 shares of common stock at $499.11 per share to cover tax liabilities related to vesting restricted stock.
- On the same date, Penczek acquired 226 restricted share units and 1,046 performance-based restricted share units at $0.
- Penczek also acquired 867 employee stock options with an exercise price of $499.11, exercisable in three annual installments starting March 1, 2025.
- Following these transactions, Penczek beneficially owns 2,680 shares of common stock and 867 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing primarily reflects routine transactions related to executive compensation. There are no explicit positive or negative implications for the company's performance.
Positives
- The acquisition of restricted share units and stock options indicates a continued alignment of Penczek's interests with the company's performance.
- The vesting schedule of the stock options and restricted share units encourages long-term commitment.
Future Outlook
The vesting schedule of the restricted share units and the exercisability of the stock options in the coming years suggest a continued stake in the company's future performance by the reporting person.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in the company's stock. This filing indicates the CAO & Controller's ongoing investment in Elevance Health.
Comparison to Industry Standards
- Stock option grants and restricted stock units are common forms of executive compensation in the healthcare industry, aligning management's interests with shareholder value.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize similar equity-based compensation plans for their executives.
- The vesting schedules and exercise prices are generally structured to incentivize long-term performance and retention.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock disposal and acquisition of restricted share units and stock options. |
| 12/21/2023 | Date of dividend reinvestment plan acquisition of 4.20 shares. |
| 03/01/2025 | First vesting date for 75 restricted share units and first exercisable date for 289 stock options. |
| 03/01/2026 | Second vesting date for 75 restricted share units. |
| 03/01/2027 | Third vesting date for 76 restricted share units. |
| 03/01/2034 | Expiration date of the employee stock options. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.